Shijiazhuang Lonzeal Pharmaceuticals Co., Ltd. (referred to as Lonzeal Pharmaceuticals) was founded in 2006. It is a pharmaceutical enterprise with a whole industrial chain from intermediates, raw materials to finished dosage formulation . It implements ICH guidelines in all aspects from product research and development, production and quality management. Strengthen the standardization of quality management, adhering to the corporate philosophy of "shaping quality with professionalism and concentration", and realizing the company's purpose of "contributing to health and beauty". The company's products and production sites have been approved and certified by many regulatory agencies including USFDA, WHOPQ, China Food and Drug Administration, Brazil ANVISA and India DCGI, and continue to provide compliant and high-quality products to well-known pharmaceutical customers at home and abroad.

Lonzeal Pharmaceuticals has a drug production base located in Shijiazhuang National Biomedical Industrial Park, Hebei Province, an API and preparation R&D center located in Shijiazhuang High-tech Industrial Development Zone, and a business office in Beijing.

The main products of Lonzeal Pharmaceuticals include antiviral, antidepression and antineuralgia preparations, raw materials and the intermediates. It is already one of the world's important suppliers of anti-AIDS drug products, and supplies about 4 million AIDS patients provided medication support.